Page 33 - Third Amended News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Jaguar Health Announces Adjournment of Annual Meeting of Stockholders Until Friday, June 11, 2021 and Encourages All Shareholders to Vote ACCESSWIRE 14 May 2021, 22:43 GMT+10 Based on a preliminary review of votes cast, over 80% have voted in favor of Proposals 2, 3, 4 & 6 Meeting scheduled to reconvene June 11, 2021 at 8:30 AM Pacific Standard Time to provide time to reach quorum Reminder: Jaguar to host investor webcast Monday, May 17th at 8:30 AM Eastern Time regarding Q1 2021 financials & business updates SAN FRANCISCO, CA / ACCESSWIRE / May 14, 2021 / Jaguar Health, Inc. (NASDAQ:JAGX) ...

Share: Business optimization initiative projected to drive superior results and enhanced value in the business First-quarter cash burn better than expected Cedar Fair Entertainment Company (NYSE:FUN), a leader in regional amusement parks, water parks and immersive entertainment, today announced results for its first quarter ended March 28, 2021. "In our business, few things are more exciting and rewarding than reopening our parks each year for another FUN-filled season," said Cedar Fair President and CEO Richard A. Zimmerman. "We are pleased that all of our U.S. properties are ready to reopen...

Termination of a Material Definitive Agreement. In connection with the closing of the Merger, on the Closing Date, RigNet terminated all outstanding commitments under that certain Third Amended and Restated Credit Agreement, dated as of November 6, 2017, among RigNet, as borrower, certain of RigNet's subsidiaries party thereto as guarantors, Bank of America, N.A., as administrative agent, swingline lender and L/C issuer, BBVA Compass, as syndication agent, the lenders party thereto and Merrill Lynch, Pierce, Fenner & Smith Incorporated as sole lead arranger and sole book...

Curis Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) News provided by Share this article LEXINGTON, Mass., April 7, 2021 /PRNewswire/ --  Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, today announced that on April 1, 2021, the independent Compensation Committee of the Board of Directors of Curis approved the grant of inducement stock options to purchase a total of 167,300 shares of Curis common stock to five new employees, with a grant date of April 1, 2021 (the "Q2 2021 Inducement Grants...

Curis Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) News provided by Share this article LEXINGTON, Mass., Jan. 8, 2021 /PRNewswire/ --  Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, today announced that on January 4, 2021, the independent Compensation Committee of the Board of Directors of Curis approved the grant of inducement stock options to purchase a total of 185,000 shares of Curis common stock to three new employees, with a grant date of January 4, 2021 (the "Q1 2021 Inducement Gr...